Skip to content

Clinical trials

Completed Hepatitis C trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Status: Completed Country / region: South Korea Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20092
20102
20115
20125
20132
20142
20152
20164
20174
20182
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb12
AbbVie6
Debiopharm International SA3
Gilead Sciences3
Boehringer Ingelheim2
GlaxoSmithKline2
Atea Pharmaceuticals, Inc.1
Bukwang Pharmaceutical1
GeneOne Life Science, Inc.1
Human Genome Sciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C35
Hepatitis C, Chronic11
Acquired Immunodeficiency Syndrome2
Coinfection2
Hepatitis2
Chronic Pain1
Fibrosis1
Liver Cirrhosis1
Renal Insufficiency, Chronic1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.